Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence
- PMID: 29974322
- PMCID: PMC6209047
- DOI: 10.1007/s10897-018-0266-0
Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence
Abstract
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive degenerative muscular conditions. Carrier testing is available to at-risk females. Though carrier testing is often offered to adolescent females, it raises ethical issues related to autonomy. This study aimed to address the impact of DMD/BMD carrier testing during adolescence, to elucidate what motivates adolescents to seek testing, and to assess the carrier testing experience. Retrospective semi-structured telephone interviews were conducted with 12 women out of 28 initially contacted. Data were coded using thematic analysis. For most (8/12) participants, discovering their carrier status during adolescence appeared to have helped alleviate uncertainty. The majority (9/12) of participants felt that they had made an autonomous decision and most (10/12) seemed to have adjusted well to their test result. Reproductive factors were framed as having been a key motivator prior to testing. However, following testing, participants' views on prenatal diagnosis seemed more closely linked to their lived experience than to their test result. Just over half (7/12) the participants reported having not had the opportunity for genetic counseling prior to testing and after receiving their result, an issue that warrants further consideration.
Keywords: Adolescence; Becker muscular dystrophy; Carrier testing; Duchenne muscular dystrophy; Genetic counseling; Psychosocial; Qualitative; X-linked.
Conflict of interest statement
Conflict of Interest
Harry G. Fraser, Rebecca Z. Redmond, and Diana F. Scotcher declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Similar articles
-
Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.Neuromuscul Disord. 2016 Dec;26(12):860-864. doi: 10.1016/j.nmd.2016.09.008. Epub 2016 Sep 16. Neuromuscul Disord. 2016. PMID: 27863875 Free PMC article.
-
Prenatal diagnosis of Duchenne and Becker muscular dystrophies: Underestimated problem of the secondary prevention of monogenetic disorders.J Obstet Gynaecol Res. 2017 Jul;43(7):1111-1121. doi: 10.1111/jog.13344. Epub 2017 May 31. J Obstet Gynaecol Res. 2017. PMID: 28561990
-
[Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].Zhonghua Fu Chan Ke Za Zhi. 2019 Apr 25;54(4):226-231. doi: 10.3760/cma.j.issn.0529-567x.2019.04.003. Zhonghua Fu Chan Ke Za Zhi. 2019. PMID: 31006187 Chinese.
-
A retrospective cohort study and review of the literature about germline mosaicism in Duchenne/Becker muscular dystrophy prenatal counseling: How to estimate the recurrence risk in clinical settings?J Genet Couns. 2025 Feb;34(1):e1932. doi: 10.1002/jgc4.1932. Epub 2024 Jun 19. J Genet Couns. 2025. PMID: 38895972 Free PMC article. Review.
-
Duchenne and Becker muscular dystrophies: an Indian update on genetics and rehabilitation.Neurol India. 2008 Jul-Sep;56(3):248-53. doi: 10.4103/0028-3886.43442. Neurol India. 2008. PMID: 18974550 Review.
Cited by
-
Family Communication about Diagnostic Genetic Testing for Younger-Onset Dementia.J Pers Med. 2023 Apr 1;13(4):621. doi: 10.3390/jpm13040621. J Pers Med. 2023. PMID: 37109007 Free PMC article.
-
Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities.PLoS One. 2020 Jun 19;15(6):e0232654. doi: 10.1371/journal.pone.0232654. eCollection 2020. PLoS One. 2020. PMID: 32559196 Free PMC article.
-
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy.J Clin Med. 2021 Feb 17;10(4):820. doi: 10.3390/jcm10040820. J Clin Med. 2021. PMID: 33671409 Free PMC article. Review.
-
A framework for youth-friendly genetic counseling.J Community Genet. 2020 Apr;11(2):161-170. doi: 10.1007/s12687-019-00439-2. Epub 2019 Nov 5. J Community Genet. 2020. PMID: 31691103 Free PMC article.
-
Communicating the Spinal Muscular Atrophy diagnosis to children and the principle of autonomy.BMC Pediatr. 2022 Aug 17;22(1):489. doi: 10.1186/s12887-022-03552-3. BMC Pediatr. 2022. PMID: 35978280 Free PMC article.
References
-
- Aronson J. A pragmatic view of thematic analysis. The Qualitative Report. 1995;2(1):1–3.
-
- Borry P, Fryns JP, Schotsmans P, Dierickx K. Attitudes towards carrier testing in minors. Journal of Genetic Counseling. 2005;16:341–352. - PubMed
-
- Borry, P., Stultiëns, L., Nys, H., & Dierickx, K. (2006b). Informed consent in children and young people: an introduction. Revista Latinoamericana de Bioética, 10.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical